Searched for
GSK HORLICKS
Haleon to invest Rs 2,000 crore to set up first India plantHaleon is investing Rs 2,000 crore to build its first manufacturing plant in Pithampur, India. This move sharpens its focus on India, a fas...
Won’t transfer key technology to HUL: GSK Consumer to CourtUnilever Plc’s India unit said on December 3 it would merge GSK Consumer with itself in an all-stock deal that will give it access to Horli...
GSK Consumer Healthcare to fight case against tech transferGSK Consumer Healthcare said it will contest an attempt by Steer Engineering to block the transfer of technology that quickens the process ...
How Unilever's departing CEO outbid Nestle in Horlicks racePaul Polman agreed to pay about $1 billion more than his closest rival Nestle for GSK's consumer business.
Considering possible deal and merger of Indian unit: GlaxoSmithKlineIn response to recent press speculation, GSK confirms that consideration is being given to a potential transaction that includes a merger o...
Nestle seeks to pip Unilever to grab GSK’s consumer nutrition business as Coca-Cola opts outGSK Consumer Healthcare shares have climbed about 10% this year, outperforming the Sensex gain of 3.6%, taking it to a market cap of Rs 30,...
Buyer beware! Horlicks comes with a set of challengesThe scramble for Horlicks underlines the immense brand value of the product. GSK’s Horlicks and Boost brands have strong positioning in Ind...
Experts urge Amitabh Bachchan to dissociate himself from 'Horlicks'A GSK Consumer spokesperson said in a statement on Wednesday: “Horlicks has been a trusted household name for over 100 years and has been s...
Danone, HUL, KKR vie for GSK’s consumer businessAs per Monday’s market value, 72 per cent of GSK is worth around Rs 17,980 crore.
Minority investors to gain from GSK’s strategic reviewGSK CH’s sales are down from Rs 4,683 crore in FY14 to Rs 3,986 crore in FY17.
ITC likely to be a strong contender to buy GSK's nutrition business including HorlicksNestle, Unilever, PepsiCo may look to buy its nutrition business, but ITC ‘likely strong contender’ as malt-based brands can expand its por...
GSK may put iconic Horlicks for sale to fund $13-billion Novartis dealGSK is initiating a strategic review of Horlicks and its other consumer healthcare nutrition products to support funding the Novartis deal.
Continued pressure on Horlicks, destocking negatively impacted nutrition business: GSK
Women’s Horlicks scores big for GSK with Rs 100-crore salesClose to three-fourths of the sales of Women’s Horlicks have been driven by key markets of the flagship Horlicks — eastern and southern sta...
- GSK Consumer: Will pushing Horlicks into new categories destroy the brand?
In a radical departure from convention, GSK Consumer is pushing Horlicks, its superbrand, into new product categories. The strategy could b...
- GSK to invest Rs 300 crore in Horlicks relaunch
Packaged consumer goods company GlaxoSmithKline Consumer Healthcare (GSKCH) said it would invest over Rs 300 crore on repositioning origina...
- Horlicks, Complan slug it out over price points
A no-holds-barred legal battle has now broken out between GlaxoSmithKline and Heinz India - in the Bombay and Delhi high courts over their ...
- UK regulator finds Horlicks ad claims too tall
An inadvertent slip-up by a Nepali TV broadcaster has landed GlaxoSmithKline Consumer Healthcare’s (GSK) single-largest brand in India, Hor...
- 'Health awareness is rising in India, we just need the right positioning'
The UK-based FMCG major’s new MD in India, Zubair Ahmed, a former Gillette India chief, has started the process of rescripting the company’...
- GSK on prowl, to get global products
The pharma major is close to making key acquisitions in healthcare and OTC and launch new products.